Helping you help your heart failure patients feel better with our advanced therapies, monitoring solutions, and management services.
One in six people will develop heart failure.1,2 More than 670,000 new cases are diagnosed annually in the United States3 — 26 million patients worldwide.3 Heart failure is the most common cause of hospitalizations due to cardiovascular disease in patients over 654. These patients also face many personal challenges:
Cardiac Resynchronization Therapy (CRT) is a beneficial way to manage this disease. CRT is proven to6-14:
Our advanced therapies, monitoring solutions, and management services are designed to help you help your heart failure patients feel better — while improving the efficiency and effectiveness of heart failure care.
Ventricular Assist Device (VAD) is an effective means of managing advanced heart failure. As this therapy grows, we’re committed to partnering with you to advance the mechanical support field toward meeting these mutual goals:
Lloyd-Jones DM, et al. Circulation. 2002;106:3068-3072.
Wolinsky FD, et al. Med Care. 1997;35:1031-1043.
Ambrosy AP, et al. J Am Coll Cardiol. 2014;63:1123-1133.
Cowie MR, et al. Eur Heart J. 1997;18:208-225.
Mozaffarian D, et al. Circulation. 2016;133:e38-360.
Gold MR, et al. Reduced 30-Day Hospital Readmissions in Systolic Heart Failure Patients with Cardiac Resynchronization Therapy: Evidence from 5 Randomized Controlled Trials. Poster session – November 16, 2014 at AHA 2014.
Cleland JG, et al. N Engl J Med. 2005;352:1539-1549.
Cleland JG, et al. Eur Heart J. 2006;27:1928-1932.
Bristow MR, et al. N Engl J Med. 2004;350:2140-2150.
Abraham WT, et al. N Engl J Med. 2002;346:1845-1853.
Young JB, et al. JAMA. 2003;289:2685-2694.
Linde C, et al. J Am Coll. Cardiol. 2008;52:1834-1843.
Tang AS, et al. N Engl J Med. 2010;363:2385-2395.
Moss AJ, et al. N Engl J Med. 2009;361:1329-1338.